Evidence map›Paper›PMID 24412316›Full record

ReviewMethods (San Diego, Calif.)2014

Targeted genome engineering techniques in Drosophila.

Kelly J Beumer, Dana Carroll

Abstract readReview
In one paragraph

Review in Methods (San Diego, Calif.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Adipocyte-DerivedBiomolecules · 2025
    Article
  2. Article
  3. Article
  4. The Use ofBiomedicines · 2022
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Engineering the Drosophila Genome for Developmental Biology.Journal of developmental biology · 2017
    Review
  11. Article
  12. Article
  13. Review
  14. Neural Circuits Underlying Fly Larval Locomotion.Current pharmaceutical design · 2017
    Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Genome editing technologies: defining a path to clinic.Molecular therapy : the journal of the American Society of Gene Therapy · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kelly J BeumerDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT 84112-5650, United States. Electronic address: Kelly@biochem.utah.edu.
Dana CarrollDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT 84112-5650, United States.

Funding

Optimizing Genome Engineering with Targetable NucleasesR01GM078571 · NIGMS · UNIVERSITY OF UTAH · PI CARROLL, DANA · 2006 to 2017
$4.3M
NIGMS NIH HHS R01 GM078571
6 · The paper itself

Abstract

For a century, Drosophila has been a favored organism for genetic research. However, the array of materials and methods available to the Drosophila worker has expanded dramatically in the last decade. The most common gene targeting tools, zinc finger nucleases, TALENs, and RNA-guided CRISPR/Cas9, have all been adapted for use in Drosophila, both for simple mutagenesis and for gene editing via homologous recombination. For each tool, there exist a number of web sites, design applications, and delivery methods. The successful application of any of these tools also requires an understanding of methods for detecting successful genome modifications. This article provides an overview of the available gene targeting tools and their application in Drosophila. In lieu of simply providing a protocol for gene targeting, we direct the researcher to resources that will allow access to the latest research in this rapidly evolving field.

Indexed as

Genome, InsectAnimalsDevelopmental BiologyDrosophila melanogasterGene Expression Regulation, DevelopmentalGene TargetingGenetic EngineeringHomologous RecombinationZinc FingersCRISPRDrosophilaGene targetingHomologous recombinationNHEJNucleaseTALENZinc finger nuclease

Identifiers

PMID24412316
PMCPMC4048800

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.